Back to results
US 11,274,298 B2Granted
RNA engineered T cells for the treatment of cancer
AssigneeThe Trustees of the University of Pennsylvania
InventorsCarl H. June, Yangbing Zhao
Life of this patent
Estimating the term…
Abstract
The present invention relates to compositions and methods for generating RNA Chimeric Antigen Receptor (CAR) transfected T cells. The RNA-engineered T cells can be used in adoptive therapy to treat cancer.
Claims15
An in vitro transcribed RNA or synthetic RNA, comprising a nucleic acid sequence encoding an extracellular domain, a transmembrane domain, a costimulatory signaling region, and a signaling domain of CD3-zeta, wherein the RNA is transcribed from an in vitro transcription vector or a DNA,
- wherein the in vitro transcription vector comprises the nucleic acid sequence of SEQ ID NO:
- 4, 5, 27, or 28, and
- wherein the DNA comprises the nucleic acid sequence of any one of SEQ ID NOs:
- 6-24.
1 more element
Dependencies are inferred from the claim text.